167 related articles for article (PubMed ID: 9240636)
1. Reduction of radiation-induced xerostomia in nasopharyngeal carcinoma using CT simulation with laser patient marking and three-field irradiation technique.
Nishioka T; Shirato H; Arimoto T; Kaneko M; Kitahara T; Oomori K; Yasuda M; Fukuda S; Inuyama Y; Miyasaka K
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):705-12. PubMed ID: 9240636
[TBL] [Abstract][Full Text] [Related]
2. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
Lou J; Huang P; Ma C; Zheng Y; Chen J; Liang Y; Li H; Yin Y; Liu D; Yu G; Li D
J Appl Clin Med Phys; 2018 May; 19(3):251-260. PubMed ID: 29664218
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
[TBL] [Abstract][Full Text] [Related]
4. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
Zheng Y; Han F; Xiao W; Xiang Y; Lu L; Deng X; Cui N; Zhao C
Radiat Oncol; 2015 Jan; 10():17. PubMed ID: 25582731
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of radiation-induced changes to parotid glands following conventional radiotherapy in patients with nasopharygneal carcinoma.
Wu VW; Ying MT; Kwong DL
Br J Radiol; 2011 Sep; 84(1005):843-9. PubMed ID: 21224300
[TBL] [Abstract][Full Text] [Related]
6. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
[TBL] [Abstract][Full Text] [Related]
7. Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma.
Gai X; Wei Y; Tao H; Zhu J; Li B
Oncotarget; 2017 Apr; 8(16):27529-27540. PubMed ID: 28404877
[TBL] [Abstract][Full Text] [Related]
8. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma.
Cheng JC; Chao KS; Low D
Int J Cancer; 2001 Apr; 96(2):126-31. PubMed ID: 11291096
[TBL] [Abstract][Full Text] [Related]
9. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results.
Eisbruch A; Ship JA; Martel MK; Ten Haken RK; Marsh LH; Wolf GT; Esclamado RM; Bradford CR; Terrell JE; Gebarski SS; Lichter AS
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):469-80. PubMed ID: 8892473
[TBL] [Abstract][Full Text] [Related]
10. Parotid gland-sparing 3-dimensional conformal radiotherapy results in less severe dry mouth in nasopharyngeal cancer patients: a dosimetric and clinical comparison with conventional radiotherapy.
Jen YM; Shih R; Lin YS; Su WF; Ku CH; Chang CS; Shueng PW; Hwang JM; Liu DW; Chao HL; Lin HY; Chang LP; Shum WY; Lin CS
Radiother Oncol; 2005 May; 75(2):204-9. PubMed ID: 15908027
[TBL] [Abstract][Full Text] [Related]
11. Influence of intensity-modulated radiation therapy technique on xerostomia and related quality of life in patients treated with intensity-modulated radiation therapy for nasopharyngeal cancer.
Marucci L; Marzi S; Sperduti I; Giovinazzo G; Pinnarò P; Benassi M; Strigari L
Head Neck; 2012 Mar; 34(3):328-35. PubMed ID: 21400632
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
[TBL] [Abstract][Full Text] [Related]
13. Reduction of late complications after irregularly shaped four-field whole pelvic radiotherapy using computed tomographic simulation compared with parallel-opposed whole pelvic radiotherapy.
Yamazaki A; Shirato H; Nishioka T; Hashimoto S; Kitahara T; Kagei K; Miyasaka K
Jpn J Clin Oncol; 2000 Apr; 30(4):180-4. PubMed ID: 10830986
[TBL] [Abstract][Full Text] [Related]
14. Rules of parotid gland dose variations and shift during intensity modulated radiation therapy for nasopharyngeal carcinoma.
Wang W; Yang H; Mi Y; Hu W; Ding W; Xie Y; Cai Y; Chen X
Radiat Oncol; 2015 Jan; 10():3. PubMed ID: 25566789
[TBL] [Abstract][Full Text] [Related]
15. Temporal Evolution of Parotid Volume and Parotid Apparent Diffusion Coefficient in Nasopharyngeal Carcinoma Patients Treated by Intensity-Modulated Radiotherapy Investigated by Magnetic Resonance Imaging: A Pilot Study.
Juan CJ; Cheng CC; Chiu SC; Jen YM; Liu YJ; Chiu HC; Kao HW; Wang CW; Chung HW; Huang GS; Hsu HH
PLoS One; 2015; 10(8):e0137073. PubMed ID: 26323091
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the Parotid Glands on an Energy Spectrum CT Iodine Map to Evaluate Irradiation-Induced Acute Xerostomia in Patients With Nasopharyngeal Carcinoma.
Chen R; Xie J; Chen J; Li X; Lin Q; Xu Q; Chen Y; Wang L; Zheng R; Xu B
Technol Cancer Res Treat; 2024; 23():15330338241256814. PubMed ID: 38773777
[No Abstract] [Full Text] [Related]
17. Parotid gland mean dose as a xerostomia predictor in low-dose domains.
Gabryś HS; Buettner F; Sterzing F; Hauswald H; Bangert M
Acta Oncol; 2017 Sep; 56(9):1197-1203. PubMed ID: 28502238
[TBL] [Abstract][Full Text] [Related]
18. [Primary effect of submandibular salivary gland transfer in preventing radiation-induced xerostomia of nasopharyngeal carcinoma].
Liu XK; Zeng ZY; Hong MH; Cui NJ; Su Y; Mai HQ; Chen FJ
Ai Zheng; 2005 May; 24(5):577-81. PubMed ID: 15890101
[TBL] [Abstract][Full Text] [Related]
19. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W
Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
[TBL] [Abstract][Full Text] [Related]
20. T classification and clivus margin as risk factors for determining locoregional control by radiotherapy of nasopharyngeal carcinoma.
Jian JJ; Cheng SH; Prosnitz LR; Tsai SY; Tsai MJ; Huang AT
Cancer; 1998 Jan; 82(2):261-7. PubMed ID: 9445180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
